Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, April 11, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Intellia Therapeutics, Inc. ("Intellia" or the "Company") (NASDAQ: NTLA) investors of a class action representing...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 10, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Intellia Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 07, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Intellia Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Intellia Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 27, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Intellia Therapeutics, Inc....
-
Robbins LLP is Investigating Allegations that Intellia Therapeutics, Inc. (NTLA) Misled Investors Regarding the Viability of its Drug Candidate